ERYTHROCYTE-BINDING THERAPEUTICS

摘要

Peptides that specifically bind erythrocytes are described. These are provided as peptidic ligands having sequences that specifically bind, or as antibodies or fragments thereof that provide specific binding, to erythrocytes. The peptides may be prepared as molecular fusions with therapeutic agents, tolerizing antigens, or targeting peptides. Immimotolerance may be created by use of the fusions and choice of an antigen on a substance for which tolerance is desired.